Ever Supreme Bio Technology Co., Ltd (TPEX: 6712)
Health Care · Biotechnology · TW
NT$157.00
-2.79% today · -0.7% 1Y
Ever Supreme Bio Technology Co., Ltd (TPEX: 6712) operates in the Biotechnology industry within the Health Care sector. The company is valued at $487.43M and employs 88 people.
Over the last twelve months the share price has lost 0.7%, trading between 120.95 and 184.00.
Tweenvest scores Ever Supreme Bio Technology Co., Ltd across four factors: quality 77/100, value 60/100, growth 84/100, dividend 69/100. Its strongest factor is growth.
6712 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $487.43M
- Revenue (TTM)
- $33.98M
- P/E
- 32.06
- EPS
- 4.90
- Dividend yield
- 2.12%
- Beta (5Y)
- 0.30
- 52-week high
- NT$184.00
- 52-week low
- NT$120.95
- Avg volume (3M)
- —
- Shares outstanding
- 100.73M
- Employees
- 88
- Next earnings
- —
About Ever Supreme Bio Technology Co., Ltd
This enterprise is dedicated to the investigation, advancement, and creation of pharmaceutical treatments leveraging human mesenchymal stem cells and immune cells. Its current portfolio features UMC01, a drug candidate undergoing Phase I clinical evaluation for addressing conditions such as myocardial infarction and stroke. Additionally, ADCV01 is progressing through Phase II clinical trials as a potential therapy for aggressive brain tumors. The company also develops CAR001, an innovative chimeric antigen receptor immune cell product, alongside bone-marrow stem cells (BMSC) used in managing chronic stroke, severe osteoarthritis, and spinal cord injuries. Established in 2016, the firm operates from its headquarters in Taichung, Taiwan.
- ISIN
- TW0006712003
- Founded
- 2016
- Listed since
- Oct 26, 2018
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai Serum Bio-Technology Co., Ltd.SHSE: 688163 | $504.77M | CN¥31.21 | -10.50% |
| Shanghai MicuRx Pharmaceutical Co., Ltd.SHSE: 688373 | $496.25M | CN¥5.06 | -11.69% |
| SanBio Company LimitedTSE: 4592 | $494.90M | ¥1,001.00 | -1.77% |
| Pharmicell Co., Ltd.KOSE: A005690 | $489.67M | ₩10,880.00 | -15.40% |
| Faeth Therapeutics, Inc.NasdaqCM: FTH | $485.80M | $18.80 | -27.78% |
| Landfar Bio-medicine Co., LtdSZSE: 000504 | $481.38M | CN¥9.76 | -17.22% |
| TransThera Sciences (Nanjing), Inc.SEHK: 2617 | $481.33M | HK$9.28 | -11.07% |
| Steminent Biotherapeutics Inc.TPEX: 7729 | $479.33M | NT$193.00 | +0.78% |
Figures last refreshed Oct 18, 2026.